ENDG-4010

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameENDG-4010
Drug Alias NameENDG-4010
ClassificationDiagnostic agent (In vivo)Biologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionEndothelin receptor type B agonists
TargetsEndothelin receptor type B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Clinical)
Highest Status in ChinaN/A
Originator CompaniesEndogenx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEndogenx
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A